Receptor Life Sciences, Inc. — Form D/A
Receptor Life Sciences, Inc. of SEATTLE, WA, a company, filed a Form D amendment with the SEC on 2018-10-04. The offering totals $7.6M, of which $7.6M was reported sold. Industry: Other.
Offering
- Filed: 2018-10-04
- Form: D/A
- Accession: 0001693768-18-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $7.6M
- Amount sold: $7.6M
- Minimum investment: $25K
- Investors: 55
- Date of first sale: 2016-12-23
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-277870
Issuer
- Name: Receptor Life Sciences, Inc.
- CIK: 0001693768
- Entity type: Corporation
- Jurisdiction: WASHINGTON
- Incorporated: 2015
- Address: C/O LANE POWELL PC, SEATTLE, WA, 98101
- Phone: 206-483-2730
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Traci Carman | Director | Seattle, WA |
| Arthur Rubinfeld | Director | Seattle, WA |
| David Thomson | Director | Seattle, WA |
| Gregory Wesner | Director | Seattle, WA |
| Traci Carman | Executive Officer | Seattle, WA |
Other filings by this issuer (1)
More